Success is when the time to access an innovative treatment is reduced.
CT-SCOUT™ is a multi-device application aiming at facilitating the recruitment of patients in clinical studies...
It assists the investigational team in detecting the studies for which a patient is potentially eligible according to his/her current health conditions.
Transforms all physician into real time recruiters
Anywhere, anytime
On any device
Easy to use
1. An efficient algorithmic model
2. Real-time detection
3. Simplified
process
Crohn disease
Ulcerative colitis
Psoriasis
Atopic dermatitis
Hidradenitis suppurativa
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
200 +
studies registered (industrial & academic)
1000 +
users registered
170 +
centers in various countries (Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Switzerland, UK…)
7000 +
Patients detected
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor. CT-SCOUT™and ToTem4me facilitate the match between the patients and the studies.
50%
OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
80%
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.
0.02%
OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY
But 80% of patients would accept to participate t a clinical study.
CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
2
WEEKS SET-UP TIME
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
Assist investigational teams in their clinical research activities.
Shorten clinical trials by boosting detection of patients potentially eligible to clinical trials.
Allow patients’ earlier access to innovative and life-saving treatment.
September 30, 2024
29 October 2024 from 10:00AM to 11:30AM (CET) Register Now! Overview Clinical stage is the most expensive stage of drug development. The cost of clinical trials has increased by 100% over the past decade. It is natural, that it should be approached with careful planning and understanding of the rationale behind each item of the […]
September 30, 2024
Applied Clinical Trials Online As the field of clinical research undergoes rapid evolution, so too must the methodologies employed to safeguard patient participants. Whereas the focus of recent decades was predominantly on developing novel cardiovascular treatments for heart disease, contemporary research increasingly targets innovative therapies for conditions such as Alzheimer’s disease, cancer, and rare disorders. […]
September 30, 2024
Med City News Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes. Although health systems have seen some much-needed improvement to operating margins in recent quarters, these positive headlines mask a disturbing reality […]